Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Cash from Financing Activities (2016 - 2020)

Historic Cash from Financing Activities for Forte Biosciences (FBRX) over the last 5 years, with Q4 2020 value amounting to $42.4 million.

  • Forte Biosciences' Cash from Financing Activities changed N/A to $42.4 million in Q4 2020 from the same period last year, while for Dec 2020 it was $66.7 million, marking a year-over-year increase of 127287.89%. This contributed to the annual value of $51.9 million for FY2024, which is 11008.35% up from last year.
  • Per Forte Biosciences' latest filing, its Cash from Financing Activities stood at $42.4 million for Q4 2020.
  • Over the past 5 years, Forte Biosciences' Cash from Financing Activities peaked at $87.2 million during Q2 2017, and registered a low of -$1.8 million during Q3 2017.
  • Moreover, its 5-year median value for Cash from Financing Activities was $968000.0 (2019), whereas its average is $12.8 million.
  • As far as peak fluctuations go, Forte Biosciences' Cash from Financing Activities surged by 37905217.39% in 2017, and later tumbled by 13379.13% in 2018.
  • Over the past 5 years, Forte Biosciences' Cash from Financing Activities (Quarter) stood at -$23000.0 in 2016, then crashed by 5726.09% to -$1.3 million in 2017, then soared by 2228.21% to $28.5 million in 2018, then tumbled by 89.18% to $3.1 million in 2019, then surged by 1273.72% to $42.4 million in 2020.
  • Its Cash from Financing Activities stands at $42.4 million for Q4 2020, versus $166000.0 for Q3 2020 and $24.1 million for Q2 2020.